Prophylaxis and therapy of thrombotic diseases with subcutaneous heparin therapy
Tilsner, V.
Die Medizinische Welt 23(43): 1553-1556
1972
ISSN/ISBN: 0025-8512 PMID: 5086323 Document Number: 54565
Document emailed within 1 workday
Related Documents
Shakhbazov, S.G. 2009: Venous thrombotic complications in pregnancy: way of prophylaxis and therapy Georgian Medical News 170: 19-24Brien, W.F.; Inwood, M.J. 1992: Subcutaneous heparin therapy during pregnancy: a need for concern at the time of delivery Thrombosis and Haemostasis 67(2): 282
Selezneva, N.D.; Strizhakov, A.N.; Makatsariia, A.D.; Savchenko, V.F. 1982: Use of low doses of heparin for prophylaxis of postoperative thrombotic complications in gynecological patients Akusherstvo i Ginekologiia 11: 27-29
Kiricuta, I.; Todorutiu, C.; Risca, R. 1978: Prophylaxis of metastases formation by prolonged non-specific immunostimulation associated with heparin therapy Physiological Chemistry and Physics 10(3): 247-253
Adám, J. 1990: Postoperative thrombosis prophylaxis with subcutaneous heparin-Ca injection Therapia Hungarica 38(3): 133-136
Bernardi, P.; Cavazza, M.; Bastagli, L.; Fontana, F.; Ventura, C.; Spagnolo, N.; Guardigli, G. 1986: Anticoagulant therapy in myocardial infarct. Considerations based on data from the literature and personal results obtained by the administration of subcutaneous heparin-calcium La Clinica Terapeutica 119(2): 91-109
Gärdlund, B. 1996: Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group Lancet 347(9012): 1357-1361
Kurihara, I.; Yamaguchi, Y.; Soma, J.; Sato, H.; Ito, S.; Saito, T. 2000: Two aged patients with chronic renal failure and chronic disseminated intravascular coagulation secondary to aortic aneurysms: effect of continuous subcutaneous heparin infusion therapy Nihon Jinzo Gakkai Shi 42(7): 603-607
Heine, H.; Schmidt, H.; Mach, H.; Jaruszewski, H. 1971: Anticoagulant therapy and prophylaxis in arterial vascular diseases Das Deutsche Gesundheitswesen 26(19): 861-868
Tzerkovsky, D.A.; Osharin, V.V.; Istomin, Y.P.; Alexandrova, E.N.; Vozmitel, M.A. 2014: Fluorescent diagnosis and photodynamic therapy for C6 glioma in combination with antiangiogenic therapy in subcutaneous and intracranial tumor models Experimental Oncology 36(2): 85-89
1983: Pathogenesis, diagnosis and therapy of ulcer diseases. 6. Therapy. Pharmacologic principles and antacid therapy Die Medizinische Welt 34(47): 14-18
Chong, B.H.; Pitney, W.R.; Castaldi, P.A. 1982: Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis in platelet aggregation Lancet 2(8310): 1246-1249
Zimmermann, R.E.; Schwering, H.; Wittrin, G.; Hollenders, T. 1981: Control of low-dose heparin therapy using photometry to detect biologically active heparin Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 52(5): 316-319
Nakagawa, M. 1993: Heparin, low molecular weight heparin, heparinoid, and antithrombin IIi therapy of disseminated intravascular coagulation Nihon Rinsho. Japanese Journal of Clinical Medicine 51(1): 87-92
Heine, H. 1983: Transcutaneous heparin therapy. Experimental histological studies with the effective combination heparin--allantoin--D panthenol Die Medizinische Welt 34(20): 602-604
Fera, M.S.; Carunchio, A.; Burattini, M.; Mazza, A.; Coletta, C.; Galati, A.; Ceci, V. 1997: Comparison of anti-arrhythmic therapy guided by the transesophageal electropharmacologic test and emperic therapy in the prophylaxis of atrial fibrillation recurrence Giornale Italiano di Cardiologia 27(2): 152-163
Eriksson, E.; Wollter, I.M.; Christenson, B.; Stigendal, L.; Risberg, B. 1988: Heparin and fibrinolysis--comparison of subcutaneous administration of unfractionated and low molecular weight heparin Thrombosis and Haemostasis 59(2): 284-288
Grygalewicz, J.; Niznikowska-Marks, M.J.; Kozierowska, T.; Ogińska, Z.; Rzacka, D. 1981: Subcutaneous administration of heparin in children. I. Heparin in small "pediatric" doses Pediatria Polska 56(7): 783-787
Jacobs, C.; Grebe, S.; Kietzmann, M.; Mischke, R. 1999: Pharmacokinetics of an unfractionated heparin (Liquemin) in the dog after intravenous and subcutaneous application based on heparin activity Deutsche Tierärztliche Wochenschrift 106(11): 478-481
Hull, R.D.; Raskob, G.E.; Rosenbloom, D.; Pineo, G.F.; Lerner, R.G.; Gafni, A.; Trowbridge, A.A.; Elliott, C.G.; Green, D.; Feinglass, J. 1997: Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective Archives of Internal Medicine 157(3): 289-294